Adrian is a biologist most satisfied by combining expermental and
computational approaches to study complex systems. He obtained
his PhD in Systems Biology from Harvard University, working with
Prof. Douglas Melton on diferentiating pancreatic beta cells in vitro to
create cell-based therapies for diabetes. He collaborated closely with
Semma Therapeutics on applying single-cell RNA sequencing to
map in vitro beta cell differentiation, and pooled genetic screening to
control this process. Adrian is a Havard University Presidential
Scholar and previously received a Harvard Stem Cell Institute Medical
Scientist Training Fellowship. He graduated summa cum laude with
an A.B. in Physics and Chemistry from Harvard College, during which
he studied the evolutionary dynamics of antibiotic resistance in
microbes. He is an MD candidate in the Harvard-MIT Health
Sciences and Technology program. Adrian loves to cook, travel and
hike and always enjoys a good new board game.